Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-01-08 to 2024-01-09
Current total value of award: $291.07
Description: 4563653462!DOXAPRAM HYDROCHLORID